Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Systemic carboplatin for retinoblastoma: change in tumour size over time.

    Abramson DH, Lawrence SD, Beaverson KL, Lee TC, Rollins IS, Dunkel IJ.

    Br J Ophthalmol. 2005 Dec;89(12):1616-9.PMID: 16299142 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age.

    Gombos DS, Kelly A, Coen PG, Kingston JE, Hungerford JL.

    Br J Ophthalmol. 2002 Jan;86(1):80-3.PMID: 11801509 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.

    Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG.

    Arch Ophthalmol. 2003 Jul;121(7):979-84.PMID: 12860801 [PubMed - indexed for MEDLINE]Related articles

    4.

    Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.

    Demirci H, Eagle RC Jr, Shields CL, Shields JA.

    Arch Ophthalmol. 2003 Aug;121(8):1125-31.PMID: 12912690 [PubMed - indexed for MEDLINE]Related articles

    5.

    New retinoblastoma tumor formation in children initially treated with systemic carboplatin.

    Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH.

    Ophthalmology. 2003 Oct;110(10):1989-94; discussion 1994-5.PMID: 14522776 [PubMed - indexed for MEDLINE]Related articles

    6.

    A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.

    Abramson DH, Frank CM, Dunkel IJ.

    Ophthalmology. 1999 Oct;106(10):1947-50.PMID: 10519590 [PubMed - indexed for MEDLINE]Related articles

    7.

    Treatment of intraocular retinoblastoma with vincristine and carboplatin.

    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.

    J Clin Oncol. 2003 May 15;21(10):2019-25.PMID: 12743157 [PubMed - indexed for MEDLINE]Related articles

    8.

    Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.

    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.

    Ophthalmology. 2004 Oct;111(10):1917-24.PMID: 15465557 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thermochemotherapy in hereditary retinoblastoma.

    Schueler AO, Jurklies C, Heimann H, Wieland R, Havers W, Bornfeld N.

    Br J Ophthalmol. 2003 Jan;87(1):90-5.PMID: 12488270 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Chemothermotherapy in the management of retinoblastoma.

    Lumbroso L, Doz F, Urbieta M, Levy C, Bours D, Asselain B, Vedrenne J, Zucker JM, Desjardins L.

    Ophthalmology. 2002 Jun;109(6):1130-6.PMID: 12045055 [PubMed - indexed for MEDLINE]Related articles

    11.

    Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.

    Schmack I, Hubbard GB, Kang SJ, Aaberg TM Jr, Grossniklaus HE.

    Am J Ophthalmol. 2006 Aug;142(2):310-5.PMID: 16876514 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma]

    Lumbroso L, Doz F, Levy C, Dendale R, Vedrenne J, Bours D, Zucker JM, Asselain B, Desjardins L.

    J Fr Ophtalmol. 2003 Feb;26(2):154-9. French. PMID: 12660589 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.

    Wilson MW, Haik BG, Liu T, Merchant TE, Rodriguez-Galindo C.

    Am J Ophthalmol. 2005 Sep;140(3):397-406.PMID: 16138999 [PubMed - indexed for MEDLINE]Related articles

    14.

    Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma.

    Picton SV, Keeble J, Holden V, Errington J, Boddy AV, Veal GJ.

    Cancer Chemother Pharmacol. 2009 Mar;63(4):749-52. Epub 2008 Jul 8.PMID: 18607591 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.

    Mulvihill A, Budning A, Jay V, Vandenhoven C, Heon E, Gallie BL, Chan HS.

    Arch Ophthalmol. 2003 Aug;121(8):1120-4.PMID: 12912689 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results.

    Levy C, Doz F, Quintana E, Pacquement H, Michon J, Schlienger P, Validire P, Asselain B, Desjardins L, Zucker JM.

    Br J Ophthalmol. 1998 Oct;82(10):1154-8.PMID: 9924303 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cavitary changes in retinoblastoma: relationship to chemoresistance.

    Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA.

    Ophthalmology. 2005 Jun;112(6):1145-50.PMID: 15885779 [PubMed - indexed for MEDLINE]Related articles

    18.

    Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.

    Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM Jr, Grossniklaus HE, Edelhauser HF, O'Brien JM.

    Ophthalmology. 2005 Jun;112(6):1151-8.PMID: 15885791 [PubMed - indexed for MEDLINE]Related articles

    19.

    Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy.

    Greenwald MJ, Strauss LC.

    Ophthalmology. 1996 Dec;103(12):1989-97.PMID: 9003332 [PubMed - indexed for MEDLINE]Related articles

    20.

    Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.

    Hayden B, Jockovich ME, Murray TG, Kralinger MT, Voigt M, Hernandez E, Feuer W, Parel JM.

    Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3717-21.PMID: 16936078 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data